Following Australian Federal and State Government funding, Luxturna (voretigene neparvovec) has become the first ocular gene therapy to be made widely available for the

1st Group – the company behind MyHealth1st – has developed an educational webinar series for optometrists, which aims to expand practice knowledge when considering

The 2022 National Aboriginal and Torres Strait Islander Eye Health Conference (NATSIEHC22) will take place on Larrakia country in Darwin this month from 22–24

Eikance 0.01% eye drops (Aspen Australia) have been registered on the Australian Register of Therapeutic Goods (ARTG) as a treatment to slow the progression